Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Nitric Oxide and Sickle Cell Pain

View source ↗

Summary

A National Institute of Nursing Research study evaluating inhaled nitric oxide for sickle cell pain has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitric Oxide (nitric oxide)

Snippet

Sponsor: National Institute of Nursing Research (NINR) | Conditions: Sickle Cell Disease, Pain | Status: TERMINATED